Correlation of PSMA-Targeted 18F-DCFPyL PET/CT Findings With Immunohistochemical and Genomic Data in a Patient With Metastatic Neuroendocrine Prostate Cancer-Reference-Cited by-同舟云学术

Correlation of PSMA-Targeted 18F-DCFPyL PET/CT Findings With Immunohistochemical and Genomic Data in a Patient With Metastatic Neuroendocrine Prostate Cancer

Published:2017-02 Issue:1 Volume:15 Page:e65-e68
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Tosoian Jeffrey J.,Gorin Michael A.,Rowe Steven P.,Andreas Darian,Szabo Zsolt,Pienta Kenneth J.,Pomper Martin G.,Lotan Tamara L.,Ross Ashley E.

Funder

Department of Defense Physician Research Training Award

Prostate Cancer Foundation Young Investigator Award

Patrick C. Walsh Investigator Grant

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference16 articles.

1. Cancer statistics, 2015;Siegel;CA Cancer J Clin,2015

2. Translational molecular imaging of prostate cancer;Kiess;Curr Radiol Rep,2013

3. Prostate-specific membrane antigen as a target for cancer imaging and therapy;Kiess;Q J Nucl Med Mol Imaging,2016

4. PET imaging of prostate-specific membrane antigen in prostate cancer: current state of the art and future challenges;Rowe;Prostate Cancer Prostatic Dis,2016

5. Shared TP53 gene mutation in morphologically and phenotypically distinct concurrent primary small cell neuroendocrine carcinoma and adenocarcinoma of the prostate;Hansel;Prostate,2009

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PSMA PET/CT imaging and its application to prostate cancer treatment;Japanese Journal of Radiology;2024-09-03

2. Clinical parameters for the prediction of occult lymph node metastasis in patients with negative PSMA-PET;Urologic Oncology: Seminars and Original Investigations;2024-04

3. Evaluating appropriateness of 18F-fluciclovine PET/CT relative to standard of care imaging guidelines and the impact of ADT on positivity: a prospective study in 62 Veterans Administration patients at a single institution;Nuclear Medicine Communications;2024-03-22

4. Gastrin-releasing peptide receptor (GRPR) as a novel biomarker and therapeutic target in prostate cancer;Annals of Medicine;2024-03-05

5. PSMA PET for Detection of Recurrence;Seminars in Nuclear Medicine;2024-01